Key Insights

Highlights

Treatment Research

1 treatments under study, led by Atorvastatin

Related Conditions

Often studied with 9 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Phase 2 (1)

Trial Status

Not Yet Recruiting1

Clinical Trials (1)

Research Network

Common Treatments

  • Atorvastatin1

Active Sponsors

  • Region Skane1

Top Investigators

Related Conditions

  • Thyroidassociated Ophthalmopathy1
  • Graves Ophthalmopathy1
  • Graves Ophthalmopathy Go1
  • Thyroid Eye Disease1
  • Graves Disease Basedows Disease1

Activity Timeline